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Stress Testing in the Obese
Are We Finally Getting the Bigger Picture?*Rolf Gebker, MD, Christopher Schneeweis, MDBerlin, GermanyObesity has reached epidemic proportions at a global
level with multiple adverse medical and societal im-
plications (1). It is a major determinant for the
development of cardiovascular risk factors such as
diabetes and hypertension, and independently pre-
disposes to cardiac conditions such as coronary artery
disease, heart failure, and sudden cardiac death (2).
Therefore, identiﬁcation of an accurate method for
cardiac risk stratiﬁcation in obese patients is of ulti-
mate importance. In addition to being a high-risk
group, obese patients, however, often present diag-
nostic challenges when we need to evaluate them for
the presence of myocardial ischemia. Basic tests such
as exercise electrocardiography are partially ham-
pered by artifacts as a result of adipose tissue.See page 462Moreover, overweight patients are often not able to
reach the minimal heart rate threshold for an
adequate test result because of general decondition-
ing. Thus, pharmacological stress testing in con-
junction with an imaging technique is the preferred
approach. Although numerous diagnostic approaches
are available, there is an apparent discrepancy between
the extent of the clinical problem associated with
obesity and the amount of published data on using
imaging-based cardiac stress testing.
Because stress echocardiography in obese subjects
is often limited by a low acoustic window, there has
been some uncertainty about the accuracy of the
test. The diagnostic accuracy can be improved by the*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the Department of Internal Medicine–Cardiology, German Heart
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have no relationships relevant to the contents of this paper to disclose.use of contrast agents, but the prognostic value of
stress echocardiography in this patient population re-
mains vague (3). Single-photon emission tomography
(SPECT) with stress perfusion analysis may be an
overall more commonly applied test in obese patients,
but it is also handicapped by suboptimal image
quality resulting from relevant photon attenuation
and a decreased signal-to-noise ratio. Currently,
there are conﬂicting data regarding the prognostic
value of a negative SPECT examination in obese
patients (4,5).
More recently, coronary computed tomography
angiography (CTA) has been established for the
assessment of CAD and is particularly regarded for
its high negative predictive value (6,7). However, the
image quality of coronary CTA is also compromised
in obese patients (8). Although newer protocols may
improve image quality and the visualization of distal
coronary vessels, the fundamental question regarding
the clinical relevance of intermediate stenoses will
continue to be unanswered, thus supporting the
imperative for functional testing (9).
Despite the abundance of data on obesity as a
cardiovascular risk factor, very little data have been
published on the characteristics, accuracy, or prog-
nostic value of stress cardiac magnetic resonance
(CMR) in this population. In this issue of iJACC,
Shah et al. (10) are the ﬁrst to report their ﬁndings
on the feasibility and usefulness of vasodilator stress
CMR perfusion imaging for the assessment of car-
diac prognosis in 285 patients with a body mass
index $30 kg/m2. The investigators should be
commended for their effort in conducting this study,
with over 89% of patients achieving diagnostic-
quality studies. CMR image quality is probably
least affected by obesity compared with the alter-
native techniques although increased body habitus
introduces noise and the larger ﬁeld of view de-
creases the in-plane resolution of the images. The
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474main limitations of CMR have been the size of the
bore and the table weight limits. This has been
mostly overcome by the recent development of
large-bore systems. Analyzing their data on a mid-
term follow-up basis, Shah et al. (10) identiﬁed
a strong association of inducible ischemia with
major adverse cardiac events (MACE), whereas
patients with neither ischemia nor late gadolinium
enhancement had a very low annual rate of 0.6 % for
MACE, which is in accordance with previous data
in nonobese patients (11).
Generally, stress testing with CMR has become
an important diagnostic and prognostic tool in the
evaluation and management of patients with known
or suspected coronary artery disease (11,12). Given
the unique advantages of CMR in providing detailed
information on function, perfusion, and scar tissue,
the results of this study do not come as a surprise.
The authors address an important topic, and their
data contribute to the deﬁnition of the clinical use-
fulness of vasodilator stress CMR for accurate risk
stratiﬁcation in this difﬁcult population.
A number of issues need to be considered before
the results of Shah et al. (10) can truly represent the
prognostic utility of stress CMR in this population.
The study was performed retrospectively over a
period of almost 10 years, including 3 different
scanners using 1.5- and 3.0-T. During recent years,
CMR myocardial perfusion techniques have ach-
ieved very high image quality with the advancement
of hardware and software settings. With the in-
creasing adaptation of wide-bore 3.0-T systems for
CMR, it is likely that the diagnostic quality of
stress CMR on obese patients will continue to
improve. The investigators do not provide more
speciﬁc information on diagnostic image quality,
and a nonobese control group was not included in
this study. Prospective inclusion of patients and
a more rigorous trial design may lead to different
results. However, the high number of diagnostic
cases and the excellent outcome data of this studysuggest a high diagnostic and prognostic value of
CMR in this study group. It is noteworthy that the
prognostic association between inducible ischemia
and MACE remained robust when patients un-
dergoing early revascularization were censored.
However, because of the limited number of hard
events, the current study does not have adequate
statistical power to deﬁne a threshold extent of
inducible ischemia in obese patients. Experience
from larger CMR trials suggests that ischemia
>10% of left ventricular myocardium deﬁnes high
risk, which is similar to prior stress nuclear im-
aging data (13,14).
There are several areas for future work. Can the
results of the current study be translated to other
CMR stress protocols, for example, dobutamine–
atropine stress CMR? Wallace et al. (15) have al-
ready demonstrated that dobutamine–atropine stress
CMR is a suitable testing modality for accurately
providing prognostic information in obese women.
Ischemia in the form of stress-inducible wall motion
abnormalities was identiﬁed as a predictor of sur-
vival. Recently, the CE-MARC (Clinical Evalua-
tion of MAgnetic Resonance imaging in Coronary
heart disease) study demonstrated that adenosine
stress CMR is more sensitive and has a higher neg-
ative predictive value than SPECT in a nonobese
group (12). Whether these results can be transferred
to obese patients will have to be addressed.
The question of which method may offer the
optimal approach in obese patients remains currently
unanswered and will need to be addressed by future
prospective studies. Nonetheless, the results from
Shah et al. (10) reﬂect an important experience in
which valuable lessons have been learned and pro-
vide encouraging evidence in the clinical role of
stress CMR in the obese patient.
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